Elicio Therapeutics, Inc.
ELTX
$8.05
$0.091.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 18.35M | 17.62M | 26.02M | 3.43M | 11.85M |
| Total Receivables | -- | -- | 2.00K | 87.00K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.60M | 1.65M | 3.08M | 2.60M | 1.34M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 980.00K | 1.42M | 1.55M | 576.00K | 941.00K |
| Total Current Assets | 20.94M | 20.69M | 30.65M | 6.69M | 14.13M |
|
|
|||||
| Total Current Assets | 20.94M | 20.69M | 30.65M | 6.69M | 14.13M |
| Net Property, Plant & Equipment | 5.91M | 6.19M | 6.45M | 6.74M | 6.99M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.30M | 1.30M | 1.29M | 2.32M | 3.36M |
| Total Assets | 28.14M | 28.18M | 38.39M | 15.75M | 24.48M |
|
|
|||||
| Total Accounts Payable | 4.04M | 1.04M | 1.98M | 1.06M | 1.11M |
| Total Accrued Expenses | 5.77M | 8.42M | 4.85M | 4.32M | 3.32M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 926.00K | 901.00K | 877.00K | 854.00K | 881.00K |
| Total Finance Division Other Current Liabilities | 680.00K | 1.17M | 1.31M | 1.36M | 641.00K |
| Total Other Current Liabilities | 680.00K | 1.17M | 1.31M | 1.36M | 641.00K |
| Total Current Liabilities | 11.41M | 11.52M | 9.02M | 7.59M | 5.95M |
|
|
|||||
| Total Current Liabilities | 11.41M | 11.52M | 9.02M | 7.59M | 5.95M |
| Long-Term Debt | -- | 20.03M | 19.84M | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.87M | 5.11M | 5.34M | 5.57M | 5.79M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.96M | 2.83M | 23.18M | 4.25M | 7.87M |
| Total Liabilities | 19.24M | 39.49M | 57.37M | 17.40M | 19.61M |
|
|
|||||
| Common Stock & APIC | 214.51M | 183.11M | 161.46M | 160.00M | 159.32M |
| Retained Earnings | -205.31M | -194.10M | -180.10M | -161.26M | -154.03M |
| Treasury Stock & Other | -294.00K | -325.00K | -352.00K | -388.00K | -420.00K |
| Total Common Equity | 8.90M | -11.31M | -18.99M | -1.65M | 4.87M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 8.90M | -11.31M | -18.99M | -1.65M | 4.87M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 8.90M | -11.31M | -18.99M | -1.65M | 4.87M |
|
|
|||||